Isoplexis Corporation

Medical Devices & EquipmentSeries DBranford, USisoplexis.com

Latest round

Series D

Last raised

Dec 2020

Total raised

$138M

Investors

12

About Isoplexis Corporation

Based in Connecticut, US, and founded in 2013 by co-founders and CEO Sean Mackay and Rong Fan, Isoplexis Corporation is a diagnostic platform that identifies patient responses at the single-cell level. The company's platform was adopted by 15 global biopharmaceutical companies by sales in June 2018, as well as almost half of the US comprehensive cancer centers. The company is listed on NASDAQ under the ticker symbol ISO. Isoplexis Corporation's platform enables clinicians to overcome the challenges of complex diseases and targeted therapies to a precise and personalized stage by providing multiplexed single-cell analysis tools that capture the omic or full end function from thousands of single cells in parallel to better understand the complex patient response. Isoplexis uses chips and solutions that work in conjunction with the IsoLight System and data processing software and informatics.

Who invested in Isoplexis Corporation

12 investors across 6 rounds

See all investors in Isoplexis Corporation

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Dec 30, 2020

    Amount

    $85M

    Investors

    Locked

  2. Series C

    Jan 9, 2020

    Amount

    $19M

    Investors

    Locked

  3. Series C

    Nov 8, 2018

    Amount

    $20M

    Investors

    Locked

  4. Series B

    Aug 25, 2017

    Amount

    $14M

    Investors

    Locked

  5. Series A

    Jul 29, 2014

    Amount

    $1.3M

    Investors

    Locked

  6. Seed

    Jun 5, 2014

    Amount

    $0.1M

    Investors

    Locked

Questions about Isoplexis Corporation

Who invested in Isoplexis Corporation?

Isoplexis Corporation has 12 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Isoplexis Corporation raised?

Isoplexis Corporation has raised 6 venture rounds. Sign up free to see how much each round raised and the total.

When did Isoplexis Corporation last raise money?

Isoplexis Corporation's most recent round on record is a Series D, in Dec 2020.

What does Isoplexis Corporation do?

Based in Connecticut, US, and founded in 2013 by co-founders and CEO Sean Mackay and Rong Fan, Isoplexis Corporation is a diagnostic platform that identifies patient responses at the single-cell level.

Where is Isoplexis Corporation headquartered?

Isoplexis Corporation is headquartered in Branford, US.

Which VCs invest in companies like Isoplexis Corporation?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Isoplexis Corporation's stage. Their profiles are linked below.

Raising like Isoplexis Corporation? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.